Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Squalene
Cat. No.:
OB0225LY-0256
Appearance:
Liquid
Purity:
≥99%
Identity:
Confirmed by NMR and GC.
Size:
Product Overview
Description:
Squalene is a naturally occurring triterpene widely found in plants, animals and microorganisms.
Synonym:
Nikko squalane EX; Super squalene; AddaVax; all-trans-Squalene; trans-Squalene; Spinacene; 111-02-4; 2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; (E,E,E,E)-Squalene; (All-E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; (E/Z)-Squalene; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene
CAS No.:
111-02-4
Compound CID:
638072
Formula:
C30H50
Formula Weight:
410.72
Specification
Relative Density:
0.855-0.865 g/cm3 at 20°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Squalene plays a role in novel drug development and cholesterol synthesis.
Library Information
Targets:
Reactive oxygen species
Pathways:
Microbiology/Virology; Immunology/Inflammation; Metabolism; NF-κB
Plate Number:
AOCL-4
Plate Location:
c2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
3 mg/mL; 7.3 mM
